Current therapeutic paradigm for the treatment of non-Hodgkin's lymphoma

被引：19

作者：

Fisher, RI

机构：

[1] Loyola Univ, Med Ctr, Cardinal Bernardin Canc Ctr, Maywood, IL 60153 USA

[2] SW Oncol Grp, Lymphoma Comm, San Antonio, TX USA

来源：

SEMINARS IN ONCOLOGY | 2000年 / 27卷 / 06期

关键词：

D O I：

10.1053/sonc.2000.20434

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2 / 8

页数：7

共 35 条

[1]

ANDERSON T, 1977, CANCER TREAT REP, V61, P1057

[2]

CANELLOS GP, 1975, BRIT J CANCER, V31, P474

[3]

Chan WC, 1997, BLOOD, V89, P3909

[4]

Coiffier B, 1998, BLOOD, V92, P1927

[5] RANDOMIZED COMPARISON OF MACOP-B WITH CHOP IN PATIENTS WITH INTERMEDIATE-GRADE NON-HODGKINS-LYMPHOMA [J].

COOPER, IA ;

WOLF, MM ;

ROBERTSON, TI ;

FOX, RM ;

MATTHEWS, JP ;

STONE, JM ;

DING, JC ;

DART, G ;

MATTHEWS, J ;

FIRKIN, FC ;

LOWENTHAL, RM ;

IRONSIDE, P .

JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (04) :769-778

[6] Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy [J].

Czuczman, MS ;

Grillo-López, AJ ;

White, CA ;

Saleh, M ;

Gordon, L ;

LoBuglio, AF ;

Jonas, C ;

Klippenstein, D ;

Dallaire, B ;

Varns, C .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :268-276

[7] LONG-TERM FOLLOW-UP OF PATIENTS WITH LOW-GRADE MALIGNANT-LYMPHOMAS TREATED WITH DOXORUBICIN-BASED CHEMOTHERAPY OR CHEMOIMMUNOTHERAPY [J].

DANA, BW ;

DAHLBERG, S ;

NATHWANI, BN ;

CHASE, E ;

COLTMAN, C ;

MILLER, TP ;

FISHER, RI .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (04) :644-651

[8] Interferon alfa consolidation after intensive chemotherapy does not prolong the progression-free survival of patients with low-grade non-Hodgkin's lymphoma: Results of the Southwest Oncology Group randomized phase III study 8809 [J].

Fisher, RI ;

Dana, BW ;

LeBlanc, M ;

Kjeldsberg, C ;

Forman, JD ;

Unger, JM ;

Balcerzak, SP ;

Gaynor, ER ;

Roy, V ;

Miller, T .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (10) :2010-2016

[9] COMPARISON OF A STANDARD REGIMEN (CHOP) WITH 3 INTENSIVE CHEMOTHERAPY REGIMENS FOR ADVANCED NON-HODGKINS-LYMPHOMA [J].

FISHER, RI ;

GAYNOR, ER ;

DAHLBERG, S ;

OKEN, MM ;

GROGAN, TM ;

MIZE, EM ;

GLICK, JH ;

COLTMAN, CA ;

MILLER, TP .

NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (14) :1002-1006

[10] High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphoma [J].

Gianni, AM ;

Bregni, M ;

Siena, S ;

Brambilla, C ;

DiNicola, M ;

Lombardi, F ;

Gandola, L ;

Tarella, C ;

Pileri, A ;

Ravagnani, F ;

Valagussa, P ;

Bonadonna, G ;

Stern, AC ;

Magni, M ;

Caracciolo, D .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (18) :1290-1297

← 1 2 3 4 →